Bon Natural Life Limited

AI-generated fair value estimate for this company.

Method: Discounted book-value approach: FY2025 20-F (period ended 9/30/2025) shows total shareholders' equity of $57.99M / 8,128,810 total Class A+B shares = $7.13/share book value; applied a 0.20x P/B multiplier, in line with the ~0.1x-0.3x range comparable small-cap Cayman-holdco/PRC-operating-subsidiary reverse-merger stocks trade at.

Reasoning: BON's revenue fell 21.7% YoY and net income swung to a $2.0M loss in FY2025, so a DCF on a shrinking, loss-making cash-flow stream isn't reliable; the dominant valuation driver is structural - a Cayman holding company with no direct equity claim on its PRC operating subsidiaries and PRC-restricted cross-border cash transfers (per its own 20-F) - which the market prices via a steep book-value discount rather than an earnings multiple.